Inactivation of O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide.
about
Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedulesTemozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme.Dose finding and O6-alkylguanine-DNA alkyltransferase study of cisplatin combined with temozolomide in paediatric solid malignancies.Extended-schedule dose-dense temozolomide in refractory gliomasEfficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma.Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade gliomaThe efficacy of temozolomide for recurrent glioblastoma multiforme.Temozolomide: a novel oral alkylating agent.Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations.The therapeutic potential of O6-alkylguanine DNA alkyltransferase inhibitors.New developments in the treatment of malignant gliomas.Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatribNew (alternative) temozolomide regimens for the treatment of glioma.Insights into pharmacotherapy of malignant glioma in adults.Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells.Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro.Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma.O(6)-(4-bromothenyl)guanine improves the therapeutic index of temozolomide against A375M melanoma xenografts.Successful Second-Line Metronomic Temozolomide in Metastatic Paraganglioma: Case Reports and Review of the Literature.
P2860
Q33347264-1AF7BADE-384C-471E-9133-BF71DE8EB895Q33366011-18E0DFD6-7EFD-46F1-8FB5-190913991A66Q33368246-9D1D687A-A98E-4970-91BA-04865A2311C5Q33385736-19D37C85-2CD8-4D1B-8DE1-48D60D92D154Q33392078-8F16CB8F-6288-46A8-9DE2-5753403B598FQ34062033-70A6509C-D42C-479F-B8AB-DDB7B4C41B3AQ34297519-F31BDDD4-0DBA-45FC-8BCD-58AC0E10B4B2Q34734267-8260A425-1503-4AC2-A9FF-67FE3B7896C8Q36616482-FF470222-94CE-496D-9240-BE746CC3CDFDQ36964700-59E366FE-E667-4A9B-8C8F-2C4E52AEA4DBQ36972696-CEB9649A-AF22-447F-BB29-BE383685F2E8Q37099104-F73F566A-36F4-45A6-AD5C-8C2C86B2604EQ37177925-4A5177F4-2C18-45E7-ADED-846AF4894B18Q37261125-293B017E-EAE0-44F0-87F8-54B28E8DFBAFQ37575528-D76D56AB-7386-4EA6-8885-4CF365DE703EQ39908793-E41AD1DC-D3B9-42BA-8A5E-55A38E1CB598Q39993380-7F993DB4-7560-482E-86E8-CBD08EDCA112Q43072513-D2C8ED5D-38AA-422D-BB6E-2D933979EDB4Q53414888-B2651E38-0F20-42D3-9908-D29AE5A5CB2BQ55332110-D4484834-BCC1-4932-827B-41C41BF1DC5B
P2860
Inactivation of O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Inactivation of O6-alkylguanin ...... nuclear cells by temozolomide.
@ast
Inactivation of O6-alkylguanin ...... nuclear cells by temozolomide.
@en
type
label
Inactivation of O6-alkylguanin ...... nuclear cells by temozolomide.
@ast
Inactivation of O6-alkylguanin ...... nuclear cells by temozolomide.
@en
prefLabel
Inactivation of O6-alkylguanin ...... nuclear cells by temozolomide.
@ast
Inactivation of O6-alkylguanin ...... nuclear cells by temozolomide.
@en
P2093
P2860
P356
P1476
Inactivation of O6-alkylguanin ...... onuclear cells by temozolomide
@en
P2093
D Crowther
G P Margison
N Thatcher
P2860
P2888
P304
P356
10.1038/BJC.1994.82
P407
P577
1994-03-01T00:00:00Z